|
Cowen Questions Sales Growth Of Biogen Idec’s MS Drug Tecfidera
Seeking Alpha AVONEX® (interferon beta-1a), TYSABRI® (natalizumab) and RITUXAN® (rituximab) are Biogen’s other primary drugs in the MS indication. These three brought in the vast majority of the company’s $1.4 B in quarterly revenues ($736 million, $275 million and … |
Interior allows more comments for drilling rule – WBTV
|
Interior allows more comments for drilling rule
WBTV Who gets the next donated organ is a life or death matter, and now a judge is allowing two dying children in Pennsylvania to essentially jump the line. It’s an unprecedented challenge to the nation’s…More >>. It’s a life or death matter: Who gets the … |
Beta-blockers are good for patients with heart failure – Toronto NewsFIX
Toronto NewsFIX |
Beta-blockers are good for patients with heart failure
Toronto NewsFIX Some doctors feel that beta-blockers shouldn’t be used to treat patients with heart failure, because of concern over adverse effects. Yet research has suggested that beta-blockers may offer a survival advantage. To settle the question of whether beta … |
Needed: A conversation on organ donation – Philly.com (blog)
Philly.com (blog)Needed: A conversation on organ donationPhilly.com (blog)Organ donations from deceased donors resulted in the procurement of 28,600 organs that led to 24,560 transplants. … organs donated by consenting to be an organ donor (in Pennsy…
India punish sloppy Proteas – Independent Online
Independent OnlineIndia punish sloppy ProteasIndependent OnlineCardiff – Shikhar Dhawan gracefully struck a maiden ODI century to lead India to an imposing 331/7 against injury-hit South Africa in the opening Champions Trophy Group B game on Thursday. …
Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in … – Watch List News (press release)
|
Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in …
Watch List News (press release) The Monoclonal Antibodies Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the world’s leading healthcare … |
Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in … – PR Web (press release)
|
Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in …
PR Web (press release) The Monoclonal Antibodies Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the world’s leading healthcare … |
ARCA biopharma's (ABIO) Gencaro Featured in Journal JACC: Heart Failure – StreetInsider.com (subscription)
|
ARCA biopharma’s (ABIO) Gencaro Featured in Journal JACC: Heart Failure
StreetInsider.com (subscription) ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that the paper “Prevention of Atrial Fibrillation by Bucindolol is Dependent on the Beta-1 389 … |
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market … – PR Newswire UK (press release)
Monoclonal Antibodies Market in Rheumatoid Arthritis to 2018 – Market …PR Newswire UK (press release)The currently marketed monoclonal antibodies are clinically and commercially highly successful products in the rheumatoid arthritis market, constitut…
HMHP Program Helps Needy Heart Failure Patients – PR Web (press release)
HMHP Program Helps Needy Heart Failure PatientsPR Web (press release)As many as 39 recently diagnosed heart failure patients who meet specified health and financial-need criteria can participate — free of charge — in a four-month exercise rehabilitat…